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Abstract: Background: two-stage revision is considered the best treatment approach for the eradication of chronic joint 
infection. We report the outcome of 41 consecutive patients with infected hip prostheses, treated between 2000 and 2005, 
with two-stage revision using an antibiotic-loaded cement spacer. 
Methods: Patients underwent a treatment protocol which included clinical and radiographic evaluation, laboratory 
investigations, hip aspiration, 99mTc-MDP and 99mTc-leukocyte-labeled scintigraphy and intraoperative assessment. All 
patients were diagnosed with a late chronic infection and classified as B-host according to the Cierny-Mader classification 
system. 9 patients out of 41 (22%) required a second interim treatment period, with exchange of the spacer. The 
proportion of methicillin-resistant Staphylococcus was similar between the one-spacer group and two-spacer group (28% 
vs 33%), whereas the proportion of patients with three or more risk factors was significantly higher in the two-spacer 
group than in the one-spacer group (28% vs 55%, respectively). 
Results: Forty patients had final reimplantation, one patient had a resection arthroplasty. At an average follow-up of 5.3 
years no recurrence of infection occurred. The average post-operative Harris hip score improved from 41 to 80. 
Conclusions: In the treatment of two-stage revision arthroplasty the adherence to the protocol proved to be effective for 
infection eradication and final reimplantation. 
Keywords: Infection, hip, revision, spacer. 
INTRODUCTION 
  Deep periprosthetic infection in arthroplasty surgery is a 
serious problem and its treatment requires considerable 
effort and cost. Several treatment options have been 
reported: long-term antibiotic suppression [1, 2], resection 
(Girdlestone) arthroplasty [2-5], debridement with prosthesis 
retention [6], one-stage revision [7], and two-stage revision 
with antibiotic-loaded cement beads or spacer [8], or with 
spacer prosthesis [9]. 
  It is generally well accepted that it is impossible to 
eradicate chronic implant-associated infections without 
removing the foreign bodies [6]. This implies that the 
surgical options such as resection arthroplasty, one and two-
stage revision arthroplasty have the potential to eradicate 
infection. 
  However, resection arthroplasty, even if used as a 
temporary method between stages, is associated with a 
considerable loss of function, and should be considered in 
patients unfit to have an additional reconstructive procedure 
and non cooperative patients. Also a severe deficiency of 
bone stock and poor quality of local soft tissue are 
indications for an excision arthroplasty [10, 11]. In these 
cases, the eradication rate is not very high [12]. 
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  One-stage revision has the advantage of a low treatment 
cost and preservation of patient function as no interim period 
is required. In this procedure, pre-operative detection of the 
infecting pathogen is mandatory and bone cement loaded 
with antibiotics chosen according to the pathogen sensitivity 
must be used for prosthesis fixation. A concern remains 
about mid- and long-term results of cemented revision 
arthroplasty because of poor cement interdigitation [13, 14]. 
In particular reconstruction is difficult in patients with severe 
bone loss. In case of recurrence, re-revision surgery can be 
more complicated because of the difficulty of removing the 
well fixed prosthesis and cement. The eradication rate of 
one-stage revision arthroplasty compared to two-stage 
revision arthroplasty has been reported to be lower [7]. 
  With the above in mind, in the last years two-stage 
revision has become our standard therapeutic approach, not 
only for the higher eradication rate reported, but also for the 
increasing percentage of resistant pathogens [15, 17]. Two-
stage revision consists of a two-step procedure: removal of 
infected prosthesis, cement, infected and devitalized tissue, 
and implantation of a considerable number of cement beads 
or a cement spacer. After 8-12 weeks, during which a 
systemic antibiotic therapy is given, the second step is 
carried out (following normalization of the serological 
markers of infection) which consists of removal of the 
cement beads or spacer, and implantation of a new 
prosthesis. 
  The possibility exists that the prosthesis which is 
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after resterilisation. Few cases are described in literature for 
the treatment of knee periprosthetic infections [9, 16]. Even 
if authors report good results, this technique is not very 
diffused because of the risk that prosthetic spacers serve as 
good substrate for bacterial adherence. 
  Even though initially resection arthroplasty or antibiotic-
loaded cement beads were used in the interim period, these 
options did not allow maintenance of patient function and 
leg length. Moreover, the second stage required significant 
effort for the surgeon because of adhesions and soft tissue 
contracture around the pathologic hip. To address this 
problem, many surgeons shifted to the use of a temporary 
articulating cement spacer. 
  Many studies have reported good results using cement 
spacers, both in terms of function in the interim period and 
also fewer complications after the second operation [18-21]. 
Therefore, two-stage revision with an antibiotic-loaded 
cement spacer has become the gold-standard for the 
treatment of infected hip prostheses [22]. Articulated spacers 
may be used in this interim period. Recently, several reports 
about the articulated spacer PROSTALAC (prosthesis of 
antibiotic-loaded acrylic cement) have shown good results 
[10-18, 23]. This system, available only in North America, is 
a THA design spacer consisting of a thin polyethylene 
acetabular liner and a femoral stem covered by antibiotic-
loaded cement. 
  More recently, industrially preformed spacers (Spacer-
G
1) in different sizes have become available worldwide, and 
good results have been reported [24-26]. Protocols for the 
treatment of an infected hip arthroplasty may be difficult to 
carry out as planned, because they depend on several factors, 
such as patient general condition, number and type of 
pathogens, sensitivity to antibiotics, infection extent. 
Furthermore, infections caused by an antibiotic-resistant 
organism have increased [15] making this procedure even 
more difficult. Even if the infection is deemed eradicated 
before the second stage operation, infection may be 
identified at the time of the second stage operation or after 
the operation, when the results of intraoperative cultures 
become available. 
  The purpose of this study is to report the treatment 
outcome of deep periprosthetic infections treated with two-
stage revision arthroplasty using preformed antibiotic-loaded 
spacers, and to evaluate the effectiveness of the treatment 
method and our protocol. 
MATERIAL AND METHODS 
  We retrospectively reviewed the treatment outcome of 41 
consecutive patients (41 hips) with infected hip prostheses 
treated with two-stage revision with antibiotic-loaded cement 
spacers in our institution between 2000 and 2005. Sixteen 
patients were men and 25 were women. The average age of 
the patients at first stage surgery was 59 years (range, 28-79 
years). 
  Periprosthetic infection was diagnosed through clinical 
and radiographic evaluation, simple laboratory investigations 
(erythrocyte sedimentation rate, ESR; C-reactive protein, 
                                                 
1Spacer-G is distributed in US with the brand name InterSpace
® for Hip by 
Exactech Inc., Gainesville, FL, USA. 
CRP; white blood cell, WBC) hip aspiration, 
99mTc-MDP 
and 
99mTc-leukocyte-labeled scintigraphy and intra-operative 
assessment. 
 The 
99mTc-MDP and 
99mTc-leukocyte-labeled scintigra-
phies were performed in all patients except in those cases 
with clear evidence of infection, such as the presence of a 
fistula. A sample for culture was taken either from the fistula 
or through hip aspiration in order to isolate the organism and 
to be aware of its sensitivity and possible resistance to 
antibiotics before the first stage. 
  The pre-operative clinical evaluation included general 
health status, patient history, pain and wound condition. Pre-
operative plain radiographs included anterior-posterior view 
of the pelvis and lateral view of the hip joint were obtained 
to facilitate the radiographic evaluation of evidence of 
loosening and migration, or presence of a hidden sinus. 
  As patient’s individual risk factors influence treatment 
options, prognosis and interpretation of treatment results, we 
considered the physiological classification proposed by 
Cierny-Mader [27]: A-hosts are healthy and without healing 
deficiencies; B-hosts are compromised by one or more local 
and/or systemic comorbidities; C-hosts a host for whom the 
morbidity of treatment is worse than that imposed by the 
disease itself: C-hosts are not considered candidates for 
aggressive surgical intervention. 
  In the first stage operation we performed a thorough 
debridement, removal of all foreign bodies (prosthesis, plug, 
cement and so on) and potentially infected soft tissue. All 
operations were performed through a lateral approach. When 
it was difficult to remove the foreign bodies, extended 
trochanteric osteotomies were performed without hesitation. 
When a sinus was present Methylene Blue was injected in 
order to visualize all the potentially infected soft tissue. 
  Prior to administration of antibiotics and debridement at 
least three samples were taken for culture, from joint 
capsule, acetabulum, and femoral canal. All surgical fields 
were irrigated with a pulsed lavage system thoroughly. Both 
the acetabulum and femoral canal were reamed in order to 
remove all potentially infected and necrotic tissues and 
implant the antibiotic loaded cement spacer. 
  We used Spacer-G (Tecres S.p.A. Sommacampagna, 
Verona, Italy) in 36 cases and the StageOne
TM Cement 
Spacer Mold (Biomet
® Orthopaedics Inc., Warsaw, Indiana, 
USA) in 5 cases. Both types of cement spacers have the 
shape of a unipolar hemiarthroplasty. 
  Spacer-G is an industrially preformed device (Fig. 1) 
composed by a main structure in stainless steel coated with 
bone cement (PMMA) with gentamicin, and is available in 3 
head sizes (46-54-60mm), and 2 stem lengths (short and 
long), while the StageOne
TM Cement Spacer Mold is a 
silicone mould (Fig. 2) in four different head sizes (43-51-
57-64mm), which has to be prepared intra-operatively with 
bone cement and antibiotics. The type of spacer was selected 
according to the sensivity of the antibiogram, and also 
according to bone loss and acetabulum size. 
  When Spacer-G was used, a proximal neck cementation 
was always performed to improve or achieve stability. 
Cement was always loaded with Vancomycin (4gr added to 
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Fig. (1). Standard and long stem Spacer-G. 
 
Fig. (2). StageOne
TM cement spacer mould. 
  When the StageOne
TM Cement Spacer Mold was used, 
cement was loaded with Vancomycin (4gr each 40gr cement) 
or Vancomycin and Meropenem (2gr + 2gr each 40gr 
cement). Additionally one or two Kirschner wires were 
inserted as an endoskeleton, and antibiotic loaded cement 
was injected into the mold in a doughy state. 
  At the end of the first operation two suction drain tubes 
were inserted in the hip joint. 
  The interim period included six weeks of antibiotic 
therapy and subsequently at least one week of antibiotic 
discontinuation. Antibiotic therapy was chosen in collabo-
ration with the infectious disease specialist, if necessary. 
General and local conditions and laboratory tests were 
checked regularly. After the removal of the drain tubes on 
the second PO day, all patients were allowed to walk with 
touch-down weight bearing. The criteria for the second stage 
operation included negative ESR and CRP or gradual 
improvement of laboratory values, negative 99mTc-
leukocyte-labeled scan, and negative hip joint aspiration. If 
the patients shifted from B-host to C-host during the interim 
period, a resection arthroplasty was performed. 
  In the second stage operation the spacer was removed 
and at least three samples were taken for culture and 
antibiotic sensitivity, followed by additional debridement 
using the lavage system. 
  Revision hip arthroplasty was performed using structural 
or morcellized allograft when bone loss was severe. Post-
operative rehabilitation based on the stability of the implants 
and the patient's status was carried out. 
  Administration of prophylactic antibiotics was continued 
until the intra-operative samples were proven to be negative. 
If the results of the intra-operative samples were positive 
despite pre-operatively negative results, a targeted antibiotic 
therapy was administered for 2 weeks. If the results of the 
samples were negative, the patients were followed-up 
without antibiotic administration. If the results of laboratory 
tests were abnormal prior to the second stage operation, or if 
the leukocyte labeled bone scan or hip aspiration were 
positive, a thorough debridement was performed and the 
cement spacer was exchanged with a new one, and 
subsequently the treatment protocol of a second interim 
period was carried out till reimplantation. 
  According to the number of interim periods, all patients 
were divided into one-spacer and two-spacer groups. 
  The patients regularly underwent clinical, radiographic 
and laboratory tests. The functional outcome was evaluated 
before the first stage operation and at the time of the latest 
follow-up using the Harris Hip Score [26]. 
  The incorporation between allograft and host bone was 
examined by comparing the immediate post-operative X-ray 
with the latest one. 
RESULTS 
  In the present study all patients followed our treatment 
protocol (Fig. 3). 
Pre-Operative Assessment 
  The main clinical symptom was pain in all patients. CRP 
and/or ESR were pre-operatively elevated in most patients. 
A discharge from the fistula was seen in 11 patients, all had 
a culture made, but in only 4 was the organism identified. 
Hip aspiration was performed in the remaining 30 patients: 
in 24 patients the organism was identified. Most organisms 
identified before the first operation were Staphylococcus 
species (51%). Leukocyte-labeled scintigraphy was positive 
in 32 patients. Patients with a negative scan had a positive 
hip aspiration or elevated laboratory indexes. 
  The mean time lapse between the previous hip 
arthroplasty and the infection onset symptoms was 41.4 
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months (range, 1.5-114) months. According to the 
classification of Tsukayama et al. [6], all patients were 
diagnosed with a late chronic infection. 
  Pre-operatively all patients were classified as B-host 
according to Cierny-Mader classification [27]. Three or more 
morbidities were present in 14 patients (36%). 
The First Operation and the Interim Period 
  The short-stem Spacer-G was used in 29 patients, and the 
long-stem was used in 7 patients. In all cases the neck was 
cemented with vancomycin-loaded bone cement (4g x 40g 
PMMA). StageOne
TM Cement Spacer Mold was used in 5 
patients: in 3 patients bone cement was loaded with 
Vancomycin and Meropenem (2gr + 2gr added to each 40gr 
polymer powder prior to curing the cement), in the 
remaining 2 patients only Vancomycin (4gr per 40gr pack) 
was used. In one case the Cement Spacer Mold broke 6 days 
after the first operation, and so the spacer was exchanged 
with a new one. This case was included in the two-spacer 
group. 
  Infection was caused mainly by Staphylococcus species 
(Table  1). Methicillin-resistant Staphylococcus was 
identified in 12 of 41 patients (29.5%). Multiple organisms 
were identified in 10 patients. In only one patient the intra-
operative organism (Staphylococcus epidermidis) was 
different from the pre-operative organism (Enterobacter 
spp.). 
  After the first operation all 41 patients were regularly 
evaluated with clinical and laboratory findings. A 
99mTc-
leukocyte labeled scan was performed in all patients at least 
7 days after antibiotic treatment had been completed. Hip 
 
Fig. (3). Treatment protocol for infected hip arthroplasty. 
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aspiration was performed in 29 patients due to suspected 
infection and was negative in 21 patients. Of the 8 patients 
with positive culture, scintigraphy was negative in 5 and 
positive in 3. The 12 patients without hip aspiration had a 
good clinical status, normal laboratory values, and negative 
scintigraphy. Therefore, these patients were considered free 
of infection. Only one patient still had the symptom of 
persistent infection after antibiotic therapy in the interim 
period. Thirty-two patients (78%) fulfilled the criteria for 
reimplantation (one-spacer group). One (11%) of 9 patients 
with at least one positive result shifted from B-host to C-host 
in the interim period. This patient underwent a resection 
arthroplasty (Girdlestone), and the infection was eventually 
eradicated. As a result, the treatment protocol of a second 
interim period was performed in the remaining 8 patients 
(two-spacer group). In one of these patients it was necessary 
to evacuate an abscess in the ipsilateral iliac fossa. 
Table 1.  Organisms cultured in the First Operation 
 
Staphylococcus epidermidis (methicillin resistant)  13 (5) 
Staphylococcus aureus (methicillin resistant)  11 (4) 
Enterococcus  2 
Streptococcus  1 
Polymicrobial flora  10 
Not identified  4 
 
  In nine (28%) of the 32 patients with one cement spacer 
(one-spacer group), and in three (33%) of the 9 patients with 
two cement spacers (two-spacer group), the causative 
organism was methicillin-resistant Staphylococcus. There 
was no significant difference between the one-spacer group 
and two-spacer group regarding the ratio of methicillin-
resistant  Staphylococcus. There were three or more 
morbidities in five (55%) of 9 patients in the two-spacer 
group compared to nine (28%) of 32 patients in the one-
spacer group. The patients’ morbidities were higher in the 
two-spacer group than in the one-spacer group. 
The Second Operation 
  Forty patients, except for one patient with a Girdlestone 
arthroplasty, underwent revision hip arthroplasty using 40 
acetabular cementless cups, 34 cementless stems and six 
cemented stems. Bone allografts were used in five cases. At 
least three intra-operative cultures were taken in all 40 hips. 
The result of the three cultures showed that no organism was 
present in 25 hips, one of the three samples was positive in 
10 hips, two of the three samples were positive in two hips, 
and all three samples were positive in three hips. The 
organism was Staphylococcus epidermidis in 14 hips and 
Staphylococcus  aureus in one hip. All staphylococcus 
species were sensitive to methicillin. The 15 patients with 
positive results were administered antibiogram-tailored 
antibiotic treatment for four to six weeks. After the 
operation, all patients were regularly followed-up with 
clinical evaluation and laboratory tests. After a mean follow-
up of 5.3 years (range 4-9) no recurrence of infection has 
been detected. 
  The average post-operative Harris hip score improved 
from 41 to 80. 
Complications 
  Complications in the interim period included two 
dislocations and one breakage of the cement spacer (one 
dislocation with the Spacer-G, and one dislocation and one 
breakage with the StageOne
TM Cement Spacer Mold). Both 
dislocations were treated by surgical reduction. The breakage 
of the spacer was treated by exchanging it with a new one. 
  After the second stage operation, two patients had a 
dislocation of the revision prosthesis. One was managed with 
conservative therapy and one was treated with a revision of 
the acetabular cup. Other complications included one aseptic 
loosening of the cementless stem, treated with stem revision 
surgery, and one post-operative arterial bleeding, treated 
with embolization. 
  The 2 patients with loosening of the acetabular cup and 
cementless stem during the follow-up period had at least 
three intra-operative samples taken during the revision 
surgery. No organism was found in the revision stem, but S. 
epidermidis was isolated in the revision cup in one sample: 
the patient received antibiotic therapy for 2 weeks, and had 
no symptoms of recurrence of the infection. 
Radiographic Evaluation 
  As mentioned above, two patients had an aseptic 
loosening (one had the loosening of the cup and the other 
had the loosening of the cementless stem). All acetabular and 
femoral components, except for these two, appeared to be 
radiographically stable at the latest observation. All five 
allografts used for the patients with severe bone deficiency 
appeared to have integrated with host bone. 
DISCUSSION 
  The results of our treatment protocol are satisfactory. All 
deep periprosthetic infections were eradicated, and forty of 
41 patients had final reimplantation. 
  Nowadays, two-stage revision arthroplasty is considered 
the gold standard treatment method for deep periprosthetic 
infection [22], however it involves a high cost for the 
medical healthcare system, and much effort for patients, 
paramedical staffs and surgeons. It needs at least two 
operations to cure. In contrast, one-stage revision 
arthroplasty has the advantage of a lower cost and function 
preservation. The success of one-stage revision is highly 
associated with the correct choice of the specific antibiotics 
added to the bone cement used for prosthesis fixation. 
Hanssen and Rand [29] reported a success rate of 83% with 
antibiotic-loaded cement and a success rate of 60% without 
antibiotic-loaded cemen; Raut et al. [30, 31] reported a 
success rate of 86% in 57 hips with draining sinuses at an 
average follow-up of 7.4 years, and a success rate of 93.4% 
in patients with gram-negative infections at an average 
follow-up of 8 years. However, other authors [15, 32, 33] 
reported that the eradication rate in one-stage revision 
arthroplasty was lower than in two-stage revision 
arthroplasty when highly virulent organisms such as gram 
negative organisms, coagulase- negative staphylococci, and  
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anaerobic micro-organisms were causing the infection. 
Therefore, it has been proposed that the organism should be 
of lower virulence and antibiotic-loaded cement should be 
used when performing one-stage revision arthroplasty [35-
37]. In addition one–stage revision in patients with severe 
bone loss remains a concern due to the poor mid- or long-
term results of cemented revision arthroplasty [13, 14]. 
  The diagnosis of deep periprosthetic infection is a 
challenging problem. There is no 100% sensitive and 
specific test, and before the final reimplantation, many 
surgeons may have to face the difficult situation in which 
there is no certainty that infection has been eradicated. In our 
study all patients were managed with two-stage revision 
arthroplasty using a same protocol. In the interim period, the 
protocol included regular laboratory tests, hip aspiration, 
99mTc-leukocyte labeled scintigraphy, and the physiological 
stage Cierny-Mader classification. 
  To our knowledge, there are only a few reports which 
have dealt with deep periprosthetic infections taking into 
consideration the patient risk factors. Cierny et al. [38] 
reported the treatment result of 43 patients with 
periprosthetic infection, using an osteomyelitis classification 
system designed to stratify treatment selection according to 
patient risk factors. In this study the implant survival rate of 
the patients with three or more morbidities was 0% at two 
years follow-up. They concluded that the infection duration 
and the condition of the host are the two most important 
variables in predicting outcomes in patients with prosthetic 
infections. 
  Although 14 (36%) of 41 patients were B-host with three 
or more morbidities in our study, a final reimplantation was 
performed in 13 and a resection arthroplasty was performed 
only in one due to the worsening of the patient’s condition. 
In the 14 high-risk patients, no recurrence of the infection 
occurred up to their last follow-up visit. 
  Deep periprosthetic infection caused by resistant 
organisms has been increasing over recent decades, and 
surgery has become more and more complicated compared 
to infection caused by non-resistant organisms. Kilgus et al. 
[39] reported the outcome of 70 deep hip and knee 
periprosthetic infections and compared the results of patients 
infected with resistant organisms and non-resistant 
organisms. They found that the eradication rate of the former 
group was much lower compared to the latter group in which 
the bacterial strains were sensitive to at least one antibiotic. 
In contrast, Volin et al. [40] compared the outcomes of two 
groups of patients (a methicillin-sensitive group and a 
methicillin-resistant group) treated only with two-stage 
revision arthroplasty, and reported that the efficacy of two-
stage reconstruction was similar in both groups. 
  In our study, 12 of 41 patients (29.5%) had a methicillin-
resistant  Staphylococcus, and we did not observe any 
difference between the one-spacer group and the two-spacer 
group which had a similar methicillin-resistant proportion 
(28 and 33%, respectively). However, the proportion of 
patients with three or more risk factors was higher in the 
two-spacer group than in the one-spacer group (55 vs 28%, 
respectively). Our results demonstrate that it is more difficult 
to eradicate the infection in the patients with three or more 
risk factors. 
  In our opinion two-stage revision is more versatile for the 
strategy of infection eradication and for the choice of the 
type of reconstruction compared to one-stage revision. First, 
two-stage revision allows the assessment of response to the 
antibiotics selected. If the organism detected pre-operatively 
is different from the organism detected in the first stage, it is 
possible to change the antibiotic treatment. Second, the 
method allows reconstruction using either cementless or 
cemented components. Although the final reimplantation has 
traditionally been performed with cemented components and 
antibiotic-loaded cement, recently many authors [23, 41, 42] 
have recommended cementless reimplantation and have 
reported encouraging results not only following aseptic [43], 
but also septic loosening of hip arthroplasty. 
  In the present study cementless components were used in 
all acetabula and in 34 of 40 femurs in the final 
reimplantation. One cementless acetabular component and 
one cementless femoral component became loose post-
operatively, and were revised. As a result, all components, 
including the two newly revised components, appeared to be 
stable radiographically at the latest observation. 
  Finally, the method allows the use of allograft in patients 
with severe bone loss. In our study, morselized and bulk 
allografts were used in five patients with severe bone loss. 
The drawback is the possibility of infection recurrence: 
Masri et al. [20] reported that two of the three recurrences in 
their study had allograft bone in the final reconstruction. In 
contrast, Berry et al. [44] reported the use of bone allografts 
to reconstruct deficient acetabular and femoral bone in 
eighteen patients. At a mean of 5.3 years after 
reimplantation, only two patients had had recurrence of the 
infection. Wang and Chen [45] used a combination of 
morselized and bulk allograft in 22 patients with an 
eradication rate of 91%. Alexeeff et al. [46] reported 11 
patients with massive structural allografts in the final 
reimplantation of two-stage revision, and no recurrence at 
four years of follow-up. Similarly, in our study no recurrence 
occurred in the five patients with allografts at the last follow-
up time, and all allografts appeared to be incorporated in the 
host bone. 
  In our study Spacer-G, pre-loaded with gentamicin 1.9% 
w/w, was used in most cases and the spacer neck was 
routinely cemented using 4 g vancomycin per pack of 
cement (10% w/w). Compared to many reports, we used a 
high dose of vancomycin in the cement. It is well-known that 
use of high-dose antibiotics has the potential of systemic 
side-effects, such as nephrotoxicity. However, Springer et al. 
[34] evaluated the safety and potential complications of a 
high-dose antibiotic-loaded cement spacer for the treatment 
of an infected total knee arthroplasty treated with two-stage 
resection arthroplasty. They found that no patients showed 
any clinical evidence of systemic side-effects of the 
antibiotics. In our study no disease caused by systemic side-
effects of the antibiotics occurred. 
  As the result of hip aspiration is shown to be sometimes 
inaccurate according to several reports [47], we conducted 
hip aspiration in 29 patients with suspected infection in the 
interim period. As a result, eight patients with at least one 
positive result underwent a second interim period. Finally, 
those patients had a final reimplantation without recurrence 
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visualize periprosthetic infections using nuclear imaging 
technique have been described. Pelosi et al. [48] showed that 
sensitivity and specificity were 95.6% and 95.8% 
respectively using 
99mTc-HMPAO-leukocyte labeled 
scintigraphy by means of semiquantitative evaluation. Also 
Larikka et al. [49] conclude that leucocyte imaging improves 
the specificity of diagnosis of infected hip prostheses. 
  There are some limitations to this study. The sample size 
in this series may be considered small, however for this kind 
of pathology such a number of patients treated in a single 
Institution and with a same protocol is a consistent number. 
Secondly, no control group managed with one-stage revision 
was present, nonetheless two-stage revision is accepted 
today as the gold standard in the treatment of deep 
periprosthetic infection, and the eradication rate achieved 
stands for it. 
  In conclusion, there was no recurrence of infection in our 
study at mean follow-up of 4.3 years. If we consider a failure 
to be either no device reimplantation or a resection 
arthroplasty, the success rate of the final reimplantation was 
98% (40/41). 
  This study suggests that the success rate depends on the 
correct application of a protocol, which considers the patient 
risk factors and the meticulous evaluation of the different 
diagnostic tests. 
  We believe that the use of a standardized protocol for 
two-stage revision arthroplasty leads to successful 
eradication of infection and reconstruction. 
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